The Markers of Glutamate Metabolism in Peripheral Blood Mononuclear Cells and Neurological Complications in Lung Cancer Patients

Table 2

The concentration of glutamate and activities of GLS, GDH, and GAD in sera of lung cancer patients during chemotherapy. .

	Baseline	After 6-month chemotherapy
Glutamate (μmol/L) median; minimum–maximum	412.83; 85.41–5456.27	3971.83; 399.74–4937.04
Glutaminase (mU/L) median; minimum–maximum	1.66; 0–3.02	0.63; 0.33–2.61
Glutamate dehydrogenase (mU/mL) median; minimum–maximum	89.81; 25.73–154.88	105.78; 66.60–134.65
Glutamate decarboxylase (U/L) median; minimum–maximum	405.06; 0–1589.09	611.49; 210.32–903.60